Xolair: New Hope for Asthma and Allergy Sufferers
Article about this medication under development by Genentech, from Vanderbilt University.
FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Allergic Asthma
June 2003 article on the drug's US approval. Includes information about results of clinical trials.
Xolair - FamilyDoctor.org
Information for patients in English or Spanish.
The Johns Hopkins Gazette: May 10, 1999
Article about clinical testing of the experimental anti-allergy agent Anti-IgE, in a version called rhuMAb-E25.
Xolair
Full prescribing information from RxList.
|